MyFinsight
Home
Blog
About
Cash and cash
equivalents
$169,728K
(299.37%↑ Y/Y)
Inventory, net
$4,722K
Accounts receivable, net
$2,720K
Prepaid expenses
$1,035K
(38.37%↑ Y/Y)
Short-term investments
$881K
(-4.03%↓ Y/Y)
Other receivables
$726K
(-21.43%↓ Y/Y)
Research and development
tax credits...
$515K
(-52.27%↓ Y/Y)
Total current assets
$180,327K
(290.59%↑ Y/Y)
Operating lease
right-of-use assets
$829K
(-23.94%↓ Y/Y)
Property and equipment,
net
$469K
(194.97%↑ Y/Y)
Total assets
$181,625K
(283.04%↑ Y/Y)
Total liabilities and
shareholders' equity
$181,625K
(283.04%↑ Y/Y)
Total liabilities
$163,407K
(150.77%↑ Y/Y)
Total shareholders'
equity
$18,218K
(202.67%↑ Y/Y)
Accumulated deficit
-$485,283K
(-20.94%↓ Y/Y)
Royalty financing
obligation, long-term
$81,763K
Senior secured
convertible notes
$59,207K
(7.19%↑ Y/Y)
Total current
liabilities
$22,184K
(138.97%↑ Y/Y)
Operating lease
liabilities, net of current...
$192K
(-70.05%↓ Y/Y)
Other long-term
liabilities
$61K
Common shares, no par
value, unlimited...
$384,985K
(33.55%↑ Y/Y)
Additional paid-in capital
$62,867K
(49.02%↑ Y/Y)
Pre-funded warrants -
16,412,925 issued and...
$55,649K
(4.85%↑ Y/Y)
Accrued liabilities
$11,983K
Accounts payable
$8,454K
Deferred revenue
$1,034K
Operating lease
liabilities
$670K
(30.10%↑ Y/Y)
Other current
liabilities
$43K
Back
Back
Balance Sheet
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)
source: myfinsight.com